Evidence map›Paper›PMID 40670877›Full record

ArticleDrug delivery and translational research2026

A modeling framework for spring-driven autoinjectors with dual-chamber cartridges.

Sahab Babaee, Matthew J Hancock, Joseph M Barakat, Brandon Vuong, Kavin Kowsari, Sean S Teller, Lynn Lu, Adriel Gonzalez, Steven C Persak, Wail Rasheed

Abstract read
PubMed Publisher
In one paragraph

Article in Drug delivery and translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sahab BabaeeDevice Development and Technology, Merck Research Laboratories, Merck & Co., Inc, Rahway, NJ, 07065, USA. sahab.babaee@merck.com.ORCID http://orcid.org/0009-0001-4677-7400
Matthew J HancockVeryst Engineering LLC, Needham, MA, 02494, USA. mhancock@veryst.com.ORCID http://orcid.org/0000-0001-9820-3620
Joseph M BarakatVeryst Engineering LLC, Needham, MA, 02494, USA.ORCID http://orcid.org/0000-0001-7761-3874
Brandon VuongDevice Development and Technology, Merck Research Laboratories, Merck & Co., Inc, Rahway, NJ, 07065, USA.
Kavin KowsariDevice Development and Technology, Merck Research Laboratories, Merck & Co., Inc, Rahway, NJ, 07065, USA.
Sean S TellerVeryst Engineering LLC, Needham, MA, 02494, USA.
Lynn LuDevice Development and Technology, Merck Research Laboratories, Merck & Co., Inc, Rahway, NJ, 07065, USA.
Adriel GonzalezVeryst Engineering LLC, Needham, MA, 02494, USA.
Steven C PersakDevice Development and Technology, Merck Research Laboratories, Merck & Co., Inc, Rahway, NJ, 07065, USA.
Wail RasheedDevice Development and Technology, Merck Research Laboratories, Merck & Co., Inc, Rahway, NJ, 07065, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autoinjectors with dual-chamber cartridges (AIDCs) are single-use, self-administrable injection devices that facilitate automated reconstitution and injection of lyophilized products. We report the development and application of a physics-based model to understand and optimize AIDC behavior, predicting its response as a function of formulation properties and injection device parameters. Our model is based on the equations of motion for the AIDC's dual stoppers, as well as the ideal gas law and an experimentally derived stopper friction vs. glide speed relationship. Our model provides estimates for some of the key essential performance requirements that yield good device performance, including injection time, stopper trajectories, and the maximum diluent volume. We validated our model using experimental injection time data demonstrating good agreement for a range of diluent volumes, reconstituted solution viscosities, and stopper positions. The model allows different device and formulation configurations to be tested virtually without requiring the physical device and formulation, reducing the need for extensive experimental testing and ensuring the robustness of the injector performance for successful drug delivery. The modeling framework applies to a broad class of spring-driven AIDCs for lyophilized drug and vaccine delivery and enables informed device selection through simulation-led technical due diligence.

Indexed as

Drug Delivery SystemsModels, TheoreticalEquipment DesignFreeze DryingInjectionsSelf AdministrationAll-in-one reconstitution and injectionAutoinjector with dual-chamber cartridgeCartridge with bypass channelDrug-device combination productFreeze-dried formulationsInjection timeLyophilized drug productMicroparticle drug deliveryNanoparticulate drug deliveryPredictive model

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.